IM Cannabis annual return on equity
2020
2021
2022
2023
2024
2025
IM Cannabis Return on Equity (ROE) Growth & History (IMCC)
IM Cannabis's return on equity was −1,553.21% for fiscal 2025.
View full IM Cannabis company overviewIM Cannabis annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,553.21% | −1433.78 pp |
| 2024 | 2024-12-31 | −119.43% | −64.32 pp |
| 2023 | 2023-12-31 | −55.11% | +115.78 pp |
| 2022 | 2022-12-31 | −170.89% | −153.45 pp |
| 2021 | 2021-12-31 | −17.44% | +143.28 pp |
| 2020 | 2020-12-31 | −160.72% | — |
IM Cannabis quarterly return on equity
Q2.22
Q2.23
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −6,552.79% | — |
| Q3 2025 | 2025-09-30 | −97.56% | — |
| Q2 2025 | 2025-06-30 | −4.39% | — |
| Q1 2025 | 2025-03-31 | 5.20% | — |
| Q2 2023 | 2023-06-30 | −17.01% | −6.99 pp |
| Q2 2022 | 2022-06-30 | −10.02% | — |
IM Cannabis return on equity trends
Over the last five fiscal years, IM Cannabis's return on equity decreased from −160.72% to −1,553.21%, a change of −1392.49 percentage points. The latest reported quarter, Q4 2025, shows −6,552.79%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IM Cannabis source filings ↗